Clinical trial
A Multicenter, Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) When Used in Routine Medical Practice in Korea
NCT04317794 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) When Used in Routine Medical Practice in Korea
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 2, 2019
- Completion date
- February 5, 2027
- Enrollment
- 74 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.